ANAVEX LIFE SCIENCES CORP. Net Change in Cash
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Net Change in Cash of $18.11 million for the 3-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-02-16
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was $18.11M, a 243.43% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was $1.63M, a 74.05% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-06-30 was $1.06M, a 41.05% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$895.35K.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $7.06M.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$745.01K.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $6.92M, a 1972.76% increase from fiscal 2013.
- ANAVEX LIFE SCIENCES CORP. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $333.71K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 89 month | Cash and Cash Equivalents, Period Increase (Decrease) 92 month | Cash and Cash Equivalents, Period Increase (Decrease) 95 month | Cash and Cash Equivalents, Period Increase (Decrease) 98 month | Cash and Cash Equivalents, Period Increase (Decrease) 101 month | Cash and Cash Equivalents, Period Increase (Decrease) 104 month | Cash and Cash Equivalents, Period Increase (Decrease) 107 month | Cash and Cash Equivalents, Period Increase (Decrease) 110 month | Cash and Cash Equivalents, Period Increase (Decrease) 113 month | Cash and Cash Equivalents, Period Increase (Decrease) 116 month | Cash and Cash Equivalents, Period Increase (Decrease) 119 month | Cash and Cash Equivalents, Period Increase (Decrease) 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $18.11M 10-Q · filed 2021-02-16 | $19.74M derived: sum of 2 quarters · filed 2021-02-16 | $20.79M derived: sum of 3 quarters · filed 2021-02-16 | $19.90M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||
| 2020-09-30 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $2.69M derived: sum of 2 quarters · filed 2020-12-28 | $1.79M derived: sum of 3 quarters · filed 2020-12-28 | $7.06M 10-K · filed 2020-12-28 | ||||||||||||
| 2020-06-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $160.72K derived: sum of 2 quarters · filed 2020-08-06 | $5.43M 10-Q · filed 2020-08-06 | $6.37M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||
| 2020-03-31 | -$895.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $4.38M 10-Q · filed 2020-05-07 | $5.31M derived: sum of 3 quarters · filed 2021-02-16 | $7.11M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||
| 2019-12-31 | $5.27M 10-Q · filed 2021-02-16 | $6.21M derived: sum of 2 quarters · filed 2021-02-16 | $8.00M derived: sum of 3 quarters · filed 2021-02-16 | $6.74M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||
| 2019-09-30 | $936.42K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $2.73M derived: sum of 2 quarters · filed 2020-12-28 | $1.47M derived: sum of 3 quarters · filed 2020-12-28 | -$745.01K 10-K · filed 2020-12-28 | ||||||||||||
| 2019-06-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $534.04K derived: sum of 2 quarters · filed 2020-08-06 | -$1.68M 10-Q · filed 2020-08-06 | |||||||||||||
| 2019-03-31 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | -$3.47M 10-Q · filed 2020-05-07 | ||||||||||||||
| 2018-12-31 | -$2.22M 10-Q · filed 2020-02-06 | |||||||||||||||
| 2015-06-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $980.41K derived: sum of 2 quarters · filed 2015-08-14 | $699.19K 10-Q · filed 2015-08-14 | -$218.35K derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2015-03-31 | -$670.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | -$951.50K 10-Q · filed 2015-05-14 | -$1.87M derived: sum of 3 quarters · filed 2015-05-14 | -$2.88M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-12-31 | -$281.21K 10-Q · filed 2015-02-17 | -$1.20M derived: sum of 2 quarters · filed 2015-02-17 | -$2.21M derived: sum of 3 quarters · filed 2015-08-14 | $6.88M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-09-30 | -$917.54K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$1.93M derived: sum of 2 quarters · filed 2015-08-14 | $7.17M derived: sum of 3 quarters · filed 2015-08-14 | $6.92M 10-K · filed 2014-12-29 | ||||||||||||
| 2014-06-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $8.08M derived: sum of 2 quarters · filed 2015-08-14 | $7.83M 10-Q · filed 2015-08-14 | $8.18M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-03-31 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | $8.85M 10-Q · filed 2015-05-14 | $9.19M derived: sum of 3 quarters · filed 2015-05-14 | $9.19M derived: sum of 4 quarters · filed 2015-05-14 | $9.19M 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | -$249.15K 10-Q · filed 2015-02-17 | $94.28K derived: sum of 2 quarters · filed 2015-02-17 | $95.44K derived: sum of 3 quarters · filed 2015-02-17 | $16.14K derived: sum of 4 quarters · filed 2015-02-17 | $95.93K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $343.43K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $344.59K derived: sum of 2 quarters · filed 2014-12-29 | $265.29K derived: sum of 3 quarters · filed 2014-12-29 | $333.71K 10-K · filed 2014-12-29 | $345.07K 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $1.16K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | -$78.14K derived: sum of 2 quarters · filed 2014-08-13 | -$9.72K 10-Q · filed 2014-08-13 | -$16.55K derived: sum of 4 quarters · filed 2014-08-13 | $1.65K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | -$79.30K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | -$10.88K 10-Q/A · filed 2014-05-30 | -$17.71K derived: sum of 3 quarters · filed 2014-05-30 | -$178.16K derived: sum of 4 quarters · filed 2014-05-30 | $487.00 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $68.43K 10-Q · filed 2014-02-14 | $61.59K derived: sum of 2 quarters · filed 2014-02-14 | -$98.86K derived: sum of 3 quarters · filed 2014-02-14 | $70.71K derived: sum of 4 quarters · filed 2014-02-14 | $79.79K 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | -$6.83K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | -$167.28K derived: sum of 2 quarters · filed 2013-12-30 | $2.28K derived: sum of 3 quarters · filed 2013-12-30 | -$123.34K 10-K · filed 2013-12-30 | $11.36K 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | -$160.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $9.12K derived: sum of 2 quarters · filed 2013-08-14 | -$116.51K 10-Q · filed 2013-08-14 | -$1.20M derived: sum of 4 quarters · filed 2013-08-14 | $18.20K 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $169.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $43.95K 10-Q · filed 2013-05-17 | -$1.04M derived: sum of 3 quarters · filed 2013-05-17 | $175.01K derived: sum of 4 quarters · filed 2013-05-17 | $178.65K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | -$125.62K 10-Q · filed 2013-02-14 | -$1.21M derived: sum of 2 quarters · filed 2013-02-14 | $5.44K derived: sum of 3 quarters · filed 2013-02-14 | -$414.70K derived: sum of 4 quarters · filed 2013-02-14 | $9.08K 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $131.06K derived: sum of 2 quarters · filed 2012-12-31 | -$289.08K derived: sum of 3 quarters · filed 2012-12-31 | -$129.97K 10-K · filed 2012-12-31 | $134.70K 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $798.87K derived: sum of 2 quarters · filed 2012-08-17 | $957.99K 10-Q · filed 2012-08-17 | -$235.78K derived: sum of 4 quarters · filed 2012-08-17 | $1.22M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | -$420.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | -$261.03K 10-Q · filed 2012-05-15 | -$1.45M derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $159.11K 10-Q · filed 2012-02-14 | -$1.03M derived: sum of 2 quarters · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | -$86.33K 10-K · filed 2011-12-22 | ||||||||||||||
| 2010-06-30 | $1.11M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |